These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8251547)

  • 1. Affective and anxiety disorders and alcohol and drug dependence: diagnosis and treatment.
    Anthenelli RM; Schuckit MA
    J Addict Dis; 1993; 12(3):73-87. PubMed ID: 8251547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction.
    Schatzberg AF; Weiss RD; Brady KT; Culpepper L
    CNS Spectr; 2008 Apr; 13(4 Suppl 6):3. PubMed ID: 18408653
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood and anxiety disorders in chronic headache.
    Baskin SM; Lipchik GL; Smitherman TA
    Headache; 2006 Oct; 46 Suppl 3():S76-87. PubMed ID: 17034402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys.
    Merikangas KR; Kalaydjian A
    Curr Opin Psychiatry; 2007 Jul; 20(4):353-8. PubMed ID: 17551350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.
    Ostacher MJ
    Psychiatr Clin North Am; 2007 Mar; 30(1):69-76. PubMed ID: 17362804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major depression and comorbid substance use disorders.
    Davis L; Uezato A; Newell JM; Frazier E
    Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
    Brady KT; Verduin ML
    Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force.
    Merikangas KR; Angst J; Eaton W; Canino G; Rubio-Stipec M; Wacker H; Wittchen HU; Andrade L; Essau C; Whitaker A; Kraemer H; Robins LN; Kupfer DJ
    Br J Psychiatry Suppl; 1996 Jun; (30):58-67. PubMed ID: 8864150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin.
    Maremmani AG; Dell'Osso L; Pacini M; Popovic D; Rovai L; Torrens M; Perugi G; Maremmani I
    J Addict Dis; 2011 Apr; 30(2):123-35. PubMed ID: 21491294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity of mood and anxiety disorders.
    Kaufman J; Charney D
    Depress Anxiety; 2000; 12 Suppl 1():69-76. PubMed ID: 11098417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base.
    Hall W; Degenhardt L; Teesson M
    Addict Behav; 2009; 34(6-7):526-30. PubMed ID: 19386422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
    Teesson M; Slade T; Mills K
    Aust N Z J Psychiatry; 2009 Jul; 43(7):606-14. PubMed ID: 19530017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbid depression and anxiety spectrum disorders.
    Gorman JM
    Depress Anxiety; 1996-1997; 4(4):160-8. PubMed ID: 9166648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent perspectives on the diagnosis and treatment of generalized anxiety disorder.
    Ninan PT
    Am J Manag Care; 2001 Sep; 7(11 Suppl):S367-76. PubMed ID: 11570027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine use by incarcerated women: comorbid mood and anxiety problems.
    Vik PW
    Womens Health Issues; 2007; 17(4):256-63. PubMed ID: 17544297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical guidelines for the treatment of depressive disorders. VII. Comorbidity.
    Enns MW; Swenson JR; McIntyre RS; Swinson RP; Kennedy SH;
    Can J Psychiatry; 2001 Jun; 46 Suppl 1():77S-90S. PubMed ID: 11441774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.